Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)
Recruiting · NCT05752448 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
POSTCare Survivorship transition process
What this trial is about
This study will enroll 120 women living with ovarian cancer following completion of initial treatment. Our objective is to test an intervention designed to provide support during the survivorship transition for this population, who live with a high degree of morbidity related to the illness and its treatment as well as a high risk of recurrence. Study participants will be randomly assigned to receive survivorship care using the POSTCare-O process or usual care. The primary outcome is quality of life at 12 weeks after intervention.
Who can take part
Age range
18 Years and older
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Stage 2-4 ovarian cancer
- Treated with some combination of surgery, chemotherapy, biologics, maintenance therapy
- Within 6 months of completion of initial treatment (continued maintenance therapy okay)
- Able to provide consent in English or Spanish
Exclusion criteria
- Admission to hospice at the completion of treatment for ovary cancer
Where it is running
3 locations listed across 1 US state.
- UT Southwestern Parkland Health and Hospital System - Dallas, Texas, United States
- Dan L Duncan Comprehensive Cancer Center at the O'Quinn Medical Tower at Baylor St. Luke's Medical Center - Houston, Texas, United States
- Harris Health Smith Clinic - Houston, Texas, United States